Mirum Pharmaceuticals Inc (MIRM)
25.72
+0.61
(+2.43%)
USD |
NASDAQ |
May 01, 16:00
25.72
0.00 (0.00%)
After-Hours: 20:00
Mirum Pharmaceuticals Cash and Short Term Investments (Quarterly): 286.33M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 286.33M |
| September 30, 2023 | 306.03M |
| June 30, 2023 | 329.95M |
| March 31, 2023 | 132.07M |
| December 31, 2022 | 151.72M |
| September 30, 2022 | 185.35M |
| June 30, 2022 | 124.95M |
| March 31, 2022 | 139.91M |
| December 31, 2021 | 156.54M |
| September 30, 2021 | 190.03M |
| Date | Value |
|---|---|
| June 30, 2021 | 223.85M |
| March 31, 2021 | 213.11M |
| December 31, 2020 | 231.82M |
| September 30, 2020 | 133.75M |
| June 30, 2020 | 149.34M |
| March 31, 2020 | 159.53M |
| December 31, 2019 | 116.66M |
| September 30, 2019 | 126.26M |
| June 30, 2019 | 84.19M |
| March 31, 2019 | 49.49M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
84.19M
Minimum
Jun 2019
329.95M
Maximum
Jun 2023
181.13M
Average
156.54M
Median
Dec 2021
Cash and Short Term Investments (Quarterly) Benchmarks
| Gilead Sciences Inc | 4.718B |
| Vanda Pharmaceuticals Inc | 388.26M |
| Sarepta Therapeutics Inc | 1.676B |
| Puma Biotechnology Inc | 95.94M |
| Reneo Pharmaceuticals Inc | 102.96M |